Effect of the Exercise in Water and Ginger Supplementation on Cardio Metabolic Risk Factors in Obese Women with Breast Cancer

Document Type : Original Article


1 Department of Physiology, Islamic Azad University of Sari, Sari, Iran.

2 Faculty of Physical Education, University of Mazandaran, Mazandaran

3 Faculty of Physical Education, University of Mazandaran, Mazandaran, Iran.

4 Department of Exercise Physiology, Faculty of Physical Education, University of Mazandaran, Mazandaran, Iran.


Background and Objective: The aim of this study was to determine the effect of 6 weeks of exercise in water and ginger supplementation on cardio metabolic risk factorsin obese women with breast cancer.
Subjects and Methods: Breast cancer patients included 40 women with a mean age (48±5.8 yr), weight
(76 ± 9 kg) and fat mass (41.8±4 kg) were randomly divided into four groups; the placebo, exercise in water + placebo, ginger supplementation and ginger supplements + exercise in water groups. Ginger supplement was consummated for 6 weeks orally 4 capsule (750 mg). Progressive exercise protocol in the exercise in a pool with a width of 15 meters and a depth of 4 meter, 4/week, a sesstion 60-75 min, for 6 weeks. Data of the adiponectin and insulin resistance index were collected at pre-test and post-test and measured by Elisa and HOMA-IR methods, respectively.
Results: Both ginger supplementation and exercise in the water lead to an increase adiponectin, reduce insulin, insulin resistance and blood glucose was higher than before. However, the combination group showed higher increase of adiponectin and decrease in insulin resistance concentration, as compared to each separate experiment.
Conclusion: These findings show a protective effect of non-pharmacological strategies such as exercise, ginger supplementation and exercise in waster on the cardio-metabolic risk factors in obese women with breast cancer.


1-Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, "et al". Breast cancer in Iran: an epidemiological review. Breast J 2007 Jul-Aug; 13(4): 383-91.
2-Kumar V. Rabins pathologic basis of disease. 7th ed. Philadelphia: McGraw –Hill; 2005.
3-George SM, Bernstein L, Smith AW, Neuhouser ML, Baumgartner KB, Baumgartner RN, "et al". Central adiposity after breast cancer diagnosis is related to mortality in the Health, Eating, Activity and Lifestyle study. Breast Cancer Res Treat 2014; 146(3): 647-55.
4-Sundaram S, Le TL, Essaid L, Freemerman AJ, Huang MJ, Galanko JA, "et al". Weight Loss Reversed Obesity-Induced HGF/c-Met Pathway and Basal-Like Breast Cancer Progression. Front Oncol 2014Jul; 8(4): 175.
5-Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. EndocrRelat Cancer 2006 Jun; 13(2): 279–92.
6-Berrino F, Villarini A, Traina A, Bonanni B, Panico S, Mano MP, "et al". Metabolic syndrome and breast cancer prognosis. Breast Cancer Res Treat 2014Aug: 147(1): 159-65.
7-Ounhasuttiyanon A,  Lohsiriwat V. Metabolic syndrome and outcome after breast reconstruction. Gland Surg 2014 Feb; 3(1): 85-7.
8-Vargas-Hernández VM, Vargas-Aguilar V, Moreno-Eutimio MA, Acosta-Altamirano G, Tovar-Rodriguez J. Metabolic syndrome in breast cancer. Gland Surg 2013May; 2(2): 80-90.
9-Catsburg C, Gunter MJ, Chen C, Cote ML, Kabat GC, Nassir R, "et al". Insulin, estrogen, inflammatory markers and risk of benign proliferative breast disease. Cancer Res 2014 Jun; 74(12): 3248-58.
12-Macis D, Guerrieri-Gonzaga A, Gandini S. Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis. Int J Epidemiol 2014Aug; 43(4): 1226-36.
13-Llanos AA, Krok JL, Peng J, Pennell ML, Vitolins MZ, Degraffinreid CR, "et al". Effects of a walking intervention using mobile technology and interactive voice response on serum adipokines among postmenopausal women at increased breast cancer risk. Horm Cancer 2014Apr; 5(2): 98-103.
14-Belfiore A, Frasca F. IGF and insulin receptor signaling in breast cancer. J Mammary Gland BiolNeoplasia  2008Dec; 13(4): 381–406.
15-Schmitz KH, Holtzman J, Courneya KS, Maˆ sse LC, Duval S, Kane R. Controlled physical activity trials in cancer survivor: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2005 Jul, 14(7):1588–95.
16-Liu FX, Flatt SW, Pakiz B, Sedjo RL, Wolin KY, Blair CK,"et al". Physical activity levels of overweight or obese breast cancer survivors: correlates at entry into a weight loss intervention study. Support Care Cancer 2015 May. [Epub ahead of print] PMID: 25975675.
17-Wang S, Zhang C, Yang G, Yang Y. Biological properties of 6-gingerol: a brief review. Nat Prod Commun 2014 Jul; 9(7):1027-30.
18-Beckmann MW, Bani MR, Fasching PA. Risk and risk assessment for breast cancer: Molecular and clinical aspects. Maturitas 2007May; 57(1): 56-60.
19-Yekta ZP, Ebrahimi SM, Hosseini M, Nasrabadi AN, Sedighi S, Surmaghi MH, "et al". Ginger as a miracle against chemotherapy-induced vomiting. Iran J Nurs Midwifery Res 2012; 17(5): 325-9.
20-Panahi Y, Saadat A, Sahebkar A, Hashemian F, Taghikhani M, Abolhasani E. Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial. Integr Cancer Ther 2012 Sep; 11(3): 204-11.
21-Meredith-Jones  k, Waters  D, Legge  M, Jones  L. Upright water-based exercise to improve cardiovascular and metabolic health: A qualitative review. Complementary Therapies in Medicine 2011Apr; 19(2): 93-103.
22-Nicoll R, Henein MY. Ginger (Zingiberofficinale Roscoe): A hot remedy for cardiovascular disease? Int J Cardiol 2009 Jan; 131(3): 408-9.
23-Wong  LyE, Wong  ChK, Leung  PCh, Christopher Lam WK. The efficacy of herbal therapy on quality of life in patients with breast cancer: self-control clinical trial. Patient Prefer Adherence 2010; 4: 223-29.
24-NammiS, Sreemantula S, Roufogalis B. Protective effect of ethanolic extract of Zingiber officinal Rhizome on the development of metabolic syndrome in high-fat Diet-fed rats. Basic ClinPharmacol Toxicol 2009 May; 104(5): 366-73.
25-Weltman A, Pritzlaff CJ, Wideman L, Considine RV, Fryburg DA, Gutgesell  ME, "et al". Intensity of acute exercise does not affect serum leptin concentrations in young men. Med Sci Sports Exerc 2000Sep; 32(9): 1556-61.
26-Kim HJ, Lee JS, Kim CK. Effect of exercisetraining on muscle glucose transporter 4 proteinand intramuscular lipidcontent in elderly menwith impaired glucose tolerance. Eur J ApplPhysiol 2004 Dec; 93(3): 353-8.
27-RahimiN, Marandi M, Kargarfard M.The effect of Eight Weeks Aquatic Training on Lipid Profile of Patients who Suffer from Type II Diabetes . J Isfahan Med School 2011; 29(148): 988-96.
28-Ligibel J, Giobbie-Hurder A, Olenczuk D, Campbel N, Salinardi T, Winer E, "et al". Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors. Cancer Causes Control 2009Oct; 20(8):1523–8.
 29- Shaib GQ, Crus ML, Ball GC. Effects of Resistance Training on Insulin Sensitivity in Overweight Latino Adolescent Males. Med Sci Sports Exerc 2006; 19(2): 133-78.
30-Yavari P, Mousavizadeh M, Sadrolhafezi B, khodabakhshi R, Madani H, Mehrabi M. Effect of reproductive factorson the risk ofbreast cancer, Acase-control study. Iran J Epidemiol 2005; 1(2): 11–9.
31-Hanif Wasim, Nasser M Al-Daghri, Raja Chetty. Relationship of serum adiponectin and resistin to glucoseintolerance and fat topography in south-Asians. Cardiovas Diabetol 2006; 5(10).
32- Kraemer RR, Castracane VD.  Exercise and humoral mediators of peripheral energy balance : ghrelin and adiponectin. ExpBiol Med 2007Feb, 232(2):184-94.
33- Yokoyama H, Emoto M, Araki T. Effect of Aerobic Exercise on Plasma Adiponectin Levels and Insulin Resistance in Type 2 Diabetes .Metabolism, Endocrinology, Molecular Medicine. Diabet Care 2004Jul; 27(7): 957–75.
34-Wei-Shiung Yang, Wei-Jei Lee. Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein,Adiponectin. J Clin Endocrinol Metab2001; 86(8): 3815-9.
35- Mazzali G, Di Francesco V, Zoico E. Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women. Am J Clin Nutr 2006 Nov; 84(5): 1193-9.
36- Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG," et al".  Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol 2004 Jul; 61(1): 75–80.
37- Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, "et al". Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic. Arterioscler Thromb Vasc Biol 2000; 20:1595-9.
38-Talaei B, Mozaffari-Khosravi H, Jalali B, Mahammadi SM, Najarzadeh A, Fallahzadeh H. The Effect of Ginger on Blood Glucose, Lipid and Lipoproteins in Patients with Type 2 Diabetes: A Double-Blind Randomized Clinical Controlled Trial. JSSU 2012 Jul-Aug; 20(3): 383-95.
39- Matsumura MD, Zavorsky GS, Smoliga JM. The Effects of Pre-Exercise Ginger Supplementation on Muscle Damage and Delayed Onset Muscle Soreness. Phytother Res. 2015 Jun;29(6):887-93.
40-Habib SHM, Makpol S, Hamid NA, Das D, Ngah WZ, Yusof YAM. Ginger extract (Zingiber officinale) hasanti-cancerand anti-inflammatory effects onethionine-induced hepatomarats. Clinics 2008 Dec; 63(6): 807-13.